Christoph Binder,
Department of Laboratory Medicine MedUni Vienna,
Center for Molecular Medicine (CeMM), Austrian Academy of Sciences

Title: Oxidation-specific epitopes act as danger-associated molecular pattern in chronic inflammation

https://www.meduniwien.ac.at/hp/phd-mst/research-labs/christoph-j-binder-md-phd/

Christoph Binder is interested in the immune mechanisms of atherosclerosis and the immune recognition of oxidation-specific epitopes, and particularly how these responses can be exploited to protect from atherosclerotic lesion formation.

 

Andreas Pichlmair,
Institute of Virology,
TU Munich

Title: Organization of intracellular defense mechanisms and disturbance by viruses

https://innatelab.virologie.med.tum.de/archives/458;

https://www.virologie.med.tum.de/forschung-tum/ag-pichlmair/

Andreas Pichlmair’s group is interested in understanding interactions between pathogenic viruses and their hosts on molecular and functional level, focusing on RNA-protein and protein-protein interactions.

 

Wilfried Ellmeier,
Division of Immunobiology,
Institute of Immunology, MedUni Vienna;
Coordinator of newly granted SFB F70 ‘HDACs as regulators of T cell-mediated immunity in health and disease’
(http://www.meduniwien.ac.at/HIT/)

Title: Histone deacetylases and the control of CD4+ T cell-mediated immunity

http://www.meduniwien.ac.at/immunologie/ellmeier

The long-term research interest of Wilfried Ellmeier’s group is to characterize molecular mechanisms that regulate the development and function of T lymphocytes. They aim to provide important and medical relevant insight into the regulation of T cell-mediated immunity.

 

Robert Eferl,
Institute of Cancer Research,
MedUni Vienna

Title: CDHR5 in intestinal tissue homeostasis and cancer

https://krebsforschung.meduniwien.ac.at/forschung-research/research-focuses/cellular-and-molecular-tumor-biology/robert-eferl/

Robert Eferl works in two main topics:
1) identification of cooperative signaling pathways in cancer formation using novel mouse models.
2) functions of STAT transcription factors in inflammatory liver damage and cancer types that are associated with inflammation

Natascha Kleiter,
Section of Translational Cell Genetics,
Medical University Innsbruck

Title: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint

Natascha Kleiter has characterized NR2F6 as an intracellular immune checkpoint, directly repressing transcription of cytokine genes in T cells relevant for cancer cell rejection and therefore enhancing tumor immune surveillance.

https://phd-school.i-med.ac.at/phd-programs/doctoralprogram/molecular-cell-biology

Christian Stockmann,
Universität Zürich,
Medizinische Fakultät,
Anatomisches Institut

Title: Immune cell-driven angiogenesis affecting organ remodelling during tissue hypoxia

Christian Stockmann’s research group aims to decipher how immune cell-driven angiogenesis affects organ remodeling during tissue hypoxia and also on the role of hypoxia-inducible factors in distinct immune cell subsets and their impact on tissue fibrosis after injury as well as on the progression of malignant tumors.

http://www.anatomy.uzh.ch/en/research/stockmann.html